title: Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro.
abstract: The telomere hypothesis postulates stabilization of telomere length and telomerase activation as key events in cellular immortalization and carcinogeneses. Accordingly, telomerase has been suggested as a novel and highly selective target for design of antitumor drugs. Screening of a chemical library including 16 000 synthetic compounds yielded six that strongly inhibited telomerase activity in extracts of cultured human cells, including four isothiazolone derivatives and two unrelated compounds. The most potent inhibitor was 2-[3-(trifluoromethyl)phenyl]isothiazolin-3-one (TMPI), a concentration of 1.0 microM inhibited telomerase activity by 50% according to a telomere repeat amplification protocol (TRAP) assay. Analysis using partially purified telomerase from AH7974 rat hepatoma cells demonstrated noncompetitive inhibition with the telomere-repeat primer and mixed inhibition with the dNTPs; the inhibition constant was 2.5 microM. TMPI did not inhibit eukaryotic DNA polymerase alpha, beta, or human immunodeficiency virus reverse transcriptase (HIV RT). Thus, inhibition by TMPI was highly selective for telomerase. Inhibition by TMPI was quenched by 1 mM of dithiothreitol or glutathione, suggesting that TMPI inhibits telomerase by acting at a cysteine residue. TMPI inhibition of this enzyme may find application as an antineoplastic agent.
authors.affiliation: Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Hayakawa
authors.forename: K
authors.initials: K
authors.lastname: Nozawa
authors.forename: A
authors.initials: A
authors.lastname: Ogawa
authors.forename: N
authors.initials: N
authors.lastname: Kato
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: K i
authors.initials: Ki
authors.lastname: Akamatsu
authors.forename: M
authors.initials: M
authors.lastname: Tsuchiya
authors.forename: A
authors.initials: A
authors.lastname: Nagasaka
authors.forename: S
authors.initials: S
authors.lastname: Yoshida
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000494:pharmacology*; D004256:DNA Polymerase I / Q000378:metabolism; D019951:DNA Polymerase beta / Q000378:metabolism; D004229:Dithiothreitol / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D005978:Glutathione / Q000494:pharmacology; D054303:HIV Reverse Transcriptase / Q000378:metabolism; D018922:HL-60 Cells; D006801:Humans; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013844:Thiazoles / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: C121356:2-(3-(trifluoromethyl)phenyl)-isothiazolin-3-one; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D013439:Sulfhydryl Reagents; D013844:Thiazoles; D054303:HIV Reverse Transcriptase; D019098:Telomerase; D004256:DNA Polymerase I; D019951:DNA Polymerase beta; D005978:Glutathione; D004229:Dithiothreitol